Cytokeratin 17 (KRT17) (Basal Epithelial Marker) Antibody, IgG2b, Clone: [SPM560], Mouse, Monoclonal

Artikelnummer: NBT-3872-MSM1X-P1ABX
Artikelname: Cytokeratin 17 (KRT17) (Basal Epithelial Marker) Antibody, IgG2b, Clone: [SPM560], Mouse, Monoclonal
Artikelnummer: NBT-3872-MSM1X-P1ABX
Hersteller Artikelnummer: 3872-MSM1X-P1ABX
Alternativnummer: NBT-3872-MSM1X-P1ABX-100
Hersteller: NeoBiotechnologies
Wirt: Mouse
Kategorie: Antikörper
Applikation: FC, IF, IHC, WB
Spezies Reaktivität: Bovine, Goat, Human, Porcine, Rat
Immunogen: The cytoskeletal fraction of rat colon epithelium
Alternative Synonym: K17, Keratin Type I Cytoskeletal 17, Keratin-17, KRT17, PCHC1
Cytokeratin 17 (CK17) is a member of the Cytokeratin subfamily of intermediate filament proteins (IFPs). It is unique in that it is normally expressed in the basal cells of complex epithelia but not in stratified or simple epithelia. CK17 is expressed in the nail bed, hair follicle, sebaceous glands and other epidermal appendages. Antibody to CK17 is an excellent tool to distinguish myoepithelial cells from luminal epithelium of various glandssuch as mammary, sweat and salivary. CK17 is expressed in epithelial cells of various origins, such as bronchial epithelial cells and skin appendages. It may be considered as epithelial stem cell marker because CK17 Ab marks basal cell differentiation. CK17 can be useful when included in a panel of antibodies against TTF-1, napsin A, CK56, p63, and SOX-2 for diagnostic differentiation between lung adenocarcinoma (LADC) and lung squamous cell carcinoma (SCLC), especially for poorly-differentiated lung carcinoma. CK17 is expressed in SCLC much higher than in LADC. In breast carcinomas, approximately 20% of patients show no expression of ER, PR and Her2, which are defined as triple negative tumor. Eighty-five percent of the triple negative breast carcinomas immunoreact with basal cytokeratins including anti-CK17. Also important is that cases of triple negative breast carcinoma with expression of CK17 show an aggressive clinical course. The histologic differentiation of ampullary cancer, intestinal vs. pancreatobiliary, is very important for treatment. Usually anti-CK17 and anti-MUC1 immunoreactivity represents pancreatobiliary subtype whereas anti-MUC2 and anti-CDX-2 positivity defines intestinal subtype.
Klonalität: Monoclonal
Klon-Bezeichnung: [SPM560]
Molekulargewicht: 46kDa
Isotyp: IgG2b
NCBI: 3872
UniProt: Q04695
Formulierung: 200ug/ml of Ab Purified from Bioreactor Concentrate by Protein A/G. Prepared in 10mM PBS with 0.05% BSA & 0.05% azide. Also available WITHOUT BSA & azide at 1.0mg/ml.
Antibody Type: Monoclonal Antibody
Anwendungsbeschreibung: Flow Cytometry (1-2ug/million cells), Immunofluorescence (1-2ug/ml), Western Blot (1-2ug/ml), Immunohistochemistry (Formalin-fixed) (1-2ug/ml for 30 min at RT)(Staining of formalin-fixed tissues requires heating tissue sections in 10mM Tris with 1mM EDTA
Formalin-fixed, paraffin-embedded human skin stained with CK17 Monoclonal Antibody (SPM560).
Formalin-fixed, paraffin-embedded human skin stained with CK17 Monoclonal Antibody (SPM560).